Login / Signup

Efficacy and safety of colchicine in COVID-19: a meta-analysis of randomised controlled trials.

Kedar Gautambhai MehtaTejas PatelParagkumar D ChavdaParvati Patel
Published in: RMD open (2021)
The moderate quality evidence suggests no benefit of addition of colchicine to the standard care regimen in patients with COVID-19.
Keyphrases
  • coronavirus disease
  • quality improvement
  • sars cov
  • healthcare
  • palliative care
  • high intensity
  • pain management
  • affordable care act
  • chronic pain
  • health insurance